Anyway, the 2025-26 Houston Rockets need a math tutor. Their calculations are off. They’re losing the math game: And the ...

Igor Tudor has inherited the Tottenham Hotspur hotseat as the London club looks to avoid relegation in the final months of the Premier League season.

Acquired Business Expected to Generate $300 Million in Revenue in 12 Months Post-Close, with 70% Gross MarginHigh-Growth AI Datacenter-Comms Represents ~75% of Acquired Revenue Accelerates SiTime’s ...

The New York Knicks are back! Following a stretch so disappointing that it felt as if the team was a loss or two away from ...

While much SHOT Show coverage has historically emphasized new gun introductions, we’re increasingly seeing convention-bending (and wallet-straining) product launches in the electronic and optics ...

Amateur mathematicians are using artificial intelligence chatbots to solve long-standing problems, in a move that has taken professionals by surprise. While the problems in question aren’t the most ...

Gege Akutami and Yuji Iwasaki's sequel manga remembered to make a worthwhile story the connective tissue of its sorcery fighting series. Reading time 4 minutes When Jujutsu Kaisen‘s manga finally ...

Cathlyn Melo is an experienced anime writer from the Philippines with a Master in Business Administration. She was once a hospital employee before deciding to pursue her passion for anime and manga ...

Despite starting fairly lighthearted, recent chapters of Jujutsu Kaisen Modulo have taken a major dramatic turn; tensions between humans and Simurians have reached an all-time high after a sorcerer ...

Get a fresh look at Modulus in this latest trailer for the upcoming factory automation game. Modulus version 1.0 will be available on PC in 2026, and an expanded and updated demo is out now on Steam.

Cathlyn Melo is an experienced anime writer from the Philippines with a Master in Business Administration. She was once a hospital employee before deciding to pursue her passion for anime and manga ...

SAN DIEGO--(BUSINESS WIRE)--Solve Therapeutics, a clinical-stage biotechnology company developing best-in-class antibody-drug conjugates (ADCs) for solid tumor malignancies, today announced it has ...